NFKB1 and lymphoma: Genomic investigations indicate that several signaling pathways participate in the cell proliferation and survival of lymphoma cells in PCNSL, particularly constitutive NF-κB activation and deregulated TLR, BCR, PI3K/AKT/mTOR, and JAK-STAT pathways leading to cell survival and proliferation [18,20,24].